Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 75/100

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Wednesday, January 8, 2025 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. announced that its CEO, Raul Rodriguez, will present an overview of the company at the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. This presentation is scheduled for January 16, 2025, and aims to outline Rigel's efforts in developing therapies for hematologic disorders and cancer. Interested parties can access the live webcast through the company's website, which emphasizes Rigel's ongoing engagement with investors and stakeholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel Pharmaceuticals will present at an important industry conference.
  • The presentation showcases Rigel's commitment to advancing therapies for patients.
  • There is a significant focus on hematologic disorders and cancer, highlighting innovation.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Jan. 8, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 8:15 a.m. PT (11:15 a.m. ET) in San Francisco, CA.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When is Rigel's presentation at the J.P. Morgan Conference?

Rigel's presentation is on January 16, 2025, at 8:15 a.m. PT.

Where can I access the webcast of Rigel's presentation?

The webcast is available on Rigel's Investor Relations page at www.rigel.com.

What is Rigel Pharmaceuticals focused on?

Rigel focuses on novel therapies for hematologic disorders and cancer.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

Tags: RIGL Viatris Investor Conferences Healthcare biotechnology healthcare conference cancer therapies hematologic disorders
Last updated: Jan 8, 2025